TeraRecon has announced the release of new innovations in its flagship Aquarius iNtuition™ platform. Showcased in September at the ASNC annual meeting in Boston, this client server aims to improve efficiency within cardiac imaging. The new device is said to improve speed and accuracy in CT technology. It is workflow orientated, “available anywhere”...
READ MORENew data shows anticlotting medicine Tirofiban (AGGRASTAT®) lowers incidence of heart attack in patients who respond poorly to aspirin or Clopidogrel after elective coronary angioplasty. Dr Marco Valgimigli, Chair of Cardiology, University of Ferrara, Italy and the principal investigator of the study emphasised the significance of the findings as they...
READ MOREPhysio-Control, a wholly owned subsidiary of Medtronic Inc. received clearance from the FDA on October 3, 2008 to market the LIFEPAK 20e defibrillator / monitor within the US. It is an enhancement of the LIFEPAK 20 with a more powerful lithium-ion battery doubling ECG monitoring time. It is a non-evasive way to monitor the oxygenisation of a patient’s...
READ MOREThe Wall Street Journal has reported that Pfizer have abandoned the development of medicines for heart diseases. In the past Pfizer dominated the cardiovascular drugs sector with Lipitor being named as the worlds best selling drug in 2007. Due to a reorganisation of research they will be leaving drugs such as Lipitor to focus on other programmes including...
READ MOREPreviously only cleared for use in the coronary and peripheral blood vessels, PressureWire Certus can now be used to assess pressure measurements across heart valves and into various chambers of the heart. It can also be used in the assessment of Fractional Flow Reserve (FFR). FFR expresses the maximum achievable blood flow in a coronary artery with...
READ MOREThe SJM Confirm™ implantable cardiac monitor (ICM) is a compact device designed to help physicians detect abnormal heart rhythms in patients with unexplained symptoms. It enables the evaluation of heart rhythm signals over a longer period of time compared to standard monitoring tests and it is the smallest ICM available which can be implanted in an...
READ MORECordis have released clinical data indicating that percutaneous coronary intervention with the CYPHER sirolimuseluting coronary stent is comparable to bypass surgery in key safety measures in patients with diabetes and multi-vessel disease. The data was recently presented at the European Society of Cardiology meeting. It is the only drug-eluting stent...
READ MOREShands HealthCare at the University of Florida medical centre have installed the Toshiba Aquilion ONE dynamic volume CT. This may change the way hospitals and physicians treat and diagnose patients with cardiovascular and neurological disease. Aquilion ONE can perform single heart beat studies and capture organ perfusion, actions that cannot be performed...
READ MOREThese hybrid surgical rooms will provide optimal imaging during open and minimally invasive cardiovascular surgical procedures in a bid to enhance workflow. The combination of Philips cardiovascular x-ray systems and Steris HD 360 suites technologies and design service aims to create a flexible treatment environment in a single suite. It will in turn...
READ MOREMedtronic sponsored trials by REVERSE and PARTNERS HF have shown that cardiac resynchronisation therapy (CRT) delays the time to the first hospitalisation or death in patients with mild heart failure, and devices equipped with OptiVol® Fluid Status Monitoring identified patients who were at a significantly higher risk of having heart failure events...
READ MORE